Lv51
1510 积分 2021-08-13 加入
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial
18天前
已完结
Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
1个月前
已完结
Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC)
1个月前
已完结
Endometrial cancer
1个月前
已完结
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations
1个月前
已完结
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer
1个月前
已完结
Surgical Management of Vulvar Cancer
1个月前
已完结
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
2个月前
已完结
Genome doubling fuels ovarian cancer evolution and immune dysregulation
2个月前
已完结
SAR131675 exhibits anticancer activity on human ovarian cancer cells through inhibition of VEGFR-3/ERK1/2/AKT signaling pathway
2个月前
已完结
皖公网安备34019202002308
